{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:24:26Z","timestamp":1767705866919},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.2169\/internalmedicine.9304-21","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T22:10:09Z","timestamp":1650665409000},"page":"3559-3562","source":"Crossref","is-referenced-by-count":1,"title":["Interstitial Pneumonia with HLA-B54 Antigen that Responded Well to Erythromycin"],"prefix":"10.2169","volume":"61","author":[{"given":"Hiroshi","family":"Ishimoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriho","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kido","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Obase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ishimatsu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190: 773-779, 2014.","DOI":"10.1164\/rccm.201403-0566OC"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oda K, Yatera K, Fujino Y, et al. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Respir Investig 56: 64-71, 2018.","DOI":"10.1016\/j.resinv.2017.09.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Molyneaux PL, Cox MJ, Willis-Owen SA, et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 190: 906-913, 2014.","DOI":"10.1164\/rccm.201403-0541OC"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wilson AM, Clark AB, Cahn T, et al.; the EME-TIPAC team. Effect of co-trimoxazole (trimethoprim-sulfamethoxazole) vs placebo on death, lung transplant, or hospital admission in patients with moderate and severe idiopathic pulmonary fibrosis: the EME-TIPAC randomized clinical trial. JAMA 324: 2282-2291, 2020.","DOI":"10.1001\/jama.2020.22960"},{"key":"5","unstructured":"5. Kuse N, Abe S, Hayashi H, et al. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis. Sarcoidosis Vasc Diffuse Lung Dis 33: 242-246, 2016."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 141: 1459-1462, 1990.","DOI":"10.1164\/ajrccm\/141.6.1459"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Keicho N, Tokunaga K, Nakata K, et al. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med 158: 846-850, 1998.","DOI":"10.1164\/ajrccm.158.3.9712125"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sakamoto N, Ishimoto H, Tahara M, et al. HLA-B54 is an independent risk factor for pneumonia in Japanese patients with interstitial lung disease: a multicenter retrospective cohort study. Respir Med 188: 106612, 2021.","DOI":"10.1016\/j.rmed.2021.106612"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Behr J, Prasse A, Wirtz H, et al. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry. Eur Respir J 56: 1902279, 2020.","DOI":"10.1183\/13993003.02279-2019"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133: 226-232, 2008.","DOI":"10.1378\/chest.07-1948"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157: 1829-1832, 1998.","DOI":"10.1164\/ajrccm.157.6.9710075"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hosoda C, Baba T, Hagiwara E, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology 21: 920-926, 2016.","DOI":"10.1111\/resp.12763"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153-159, 1993.","DOI":"10.1164\/ajrccm\/147.1.153"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Acosta N, Thornton CS, Surette MG, et al. Azithromycin and the microbiota of cystic fibrosis sputum. BMC Microbiol 21: 96, 2021.","DOI":"10.1186\/s12866-021-02159-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9304-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:32:30Z","timestamp":1670038350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9304-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":14,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9304-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"9304-21"}}